My guess is he is waiting to release the results and then sometime after ASH we should know who our partner will be. He can't have it both ways. He can't say no dilution and not partner. I am real curious as to how much a big pharma thinks this chunk of Ponatinib is worth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.